1. PD-001Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. (2nd July 2019) Authors: Reni, M; Winter, J; Tortora, G; Pelzer, U; Riess, H; Chang, H; O'Reilly, E; Oh, D; Diaz, I Alés; Milella, M; Bendell, J; Garlipp, B; Tempero, M; Macarulla, T; Van Cutsem, E; Berlin, J; Goldstein, D; Lu, B; Jeanes, J; Philip, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-023FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome. (20th June 2018) Authors: Schmoll, H; Garlipp, B; Junghanß, C; Vogel, A; Kaiser, U; Florschütz, A; Kanzler, S; Hannig, C; Meinert, F; Cygon, F; Stein, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial. Issue 13 (19th August 2019) Authors: Garlipp, B; Gibbs, P; Van Hazel, G A; Jeyarajah, R; Martin, R C G; Bruns, C J; Lang, H; Manas, D M; Ettorre, G M; Pardo, F; Donckier, V; Benckert, C; Gulik, T M; Goéré, D; Schoen, M; Pratschke, J; Bechstein, W O; Cuesta, A M; Adeyemi, S; Ricke, J Journal: British journal of surgery Issue: Volume 106:Issue 13(2019) Page Start: 1837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗